Latest News and Press Releases

TORONTO, ONTARIO, March 19, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a...

Dublin, Feb. 05, 2025 (GLOBE NEWSWIRE) -- The "Cosmeceuticals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cosmeceuticals was...

Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12,...

TORONTO, ONTARIO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and...

TORONTO, ONTARIO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and...

TORONTO, ONTARIO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and...

Pacific Software Inc. appoints Dr. Robert Schiestl as Chief Science Advisor to enhance their Dermatrix technology and dietary supplements.

Pacific Software acquires Dreamaderm assets, including Dermatrix, a peptide-enhancing cosmeceutical for diverse dermatological applications.

Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Middle East and Africa Cosmeceuticals Market - A Regional and Country Level Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's...

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Global Pigmentation Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type (Vitiligo, Melasma), By Treatment...